ProfileGDS5822 / ILMN_2691204
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 0% 22% 3% 12% 5% 15% 9% 2% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 10.50
GSM1276600PDAC Late Ablation Control 215.422
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 16.33
GSM1276603PDAC Late Ablation 29.412
GSM1276604PDAC Late Ablation 35.35
GSM1303940PDAC Late Ablation_anti-CTLA4 111.215
GSM1303941PDAC Late Ablation_anti-CTLA4 26.59
GSM1303942PDAC Late Ablation_anti-CTLA4 322